Shamir Medical Center, formerly Assaf Harofeh Medical Center, is a hospital located on 60 acres, 15 kilometres southeast of Tel Aviv, Israel.

There are 891 beds in Shamir Medical center.

During the past decade, Shamir Medical center conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 11 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 7 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shamir Medical center" #1 sponsor was "Assaf-Harofeh Medical Center" with 9 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Meridian Bioscience, Inc." with 3 trials sponsored, "Scentech Medical Technologies Ltd" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shamir Medical center" #1 collaborator was "Assaf-Harofeh Medical Center" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Sheba Medical Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Shamir Medical center" are "Colitis, Ulcerative" (3 trials), "Ulcerative Colitis" (3 trials), "Colorectal Cancer" (2 trials), "Covid19" (2 trials) and "Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Shamir Medical center" in a lesser frequency.

Most popular intervention types in "Shamir Medical center" are "Drug" (25 trials), "Device" (14 trials), "Biological" (6 trials), "Diagnostic Test" (6 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Etrolizumab" (2 trials), "Guselkumab" (2 trials), "APL-2" (1 trials) and "Annabella Breast Pump" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shamir Medical center" are 42 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Shamir Medical center". 1 are not yet recruiting, 11 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Shamir Medical center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Shamir Medical center, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 16 trials that are defined as “Not Applicable".